| For: | Xu ZY, Dai ZS, Gong GZ, Zhang M. C-X-C chemokine receptor type 5+CD8+ T cells as immune regulators in hepatitis Be antigen-positive chronic hepatitis B under interferon-alpha treatment. World J Gastroenterol 2025; 31(3): 99833 [PMID: 39839901 DOI: 10.3748/wjg.v31.i3.99833] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v31/i3/99833.htm |
| Number | Citing Articles |
| 1 |
Shuyao Zhu, Zhilin Yang, Yuanyuan Wang, Xuebin Cai, Chaochao Qin. A meta-analysis of controlled clinical trials comparing peginterferon-α plus nucleos(t)ide analogs versus peginterferon-α monotherapy for HBsAg clearance or seroconversion in patients with chronic hepatitis B. Frontiers in Medicine 2026; 12 doi: 10.3389/fmed.2025.1716225
|
| 2 |
Jason M Zimmerer, Sydney Castellanos, Hatem Aldhahi, Mahmoud Abdel-Rasoul, Ravi Dhital, Masako Shimamura, Ginny L Bumgardner. Transplant mice with acute viral infection develop functionally distinct antigen-specific PD-1− and PD-1+ CXCR5+CD8+ T-cell effectors. The Journal of Immunology 2026; 215(10) doi: 10.1093/jimmun/vkag286
|